Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004930
Filing Date
2025-07-09
Accepted
2025-07-09 16:16:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4038
  Complete submission text file 0001950047-25-004930.txt   5601
Mailing Address C/O RHYTHM PHARMACEUTICALS 222 BERKELEY STREET, SUITE 1200 BOSTON MA 02116
Business Address
Smith Hunter C (Reporting) CIK: 0001636385 (see all company filings)

Type: 144

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Subject) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38223 | Film No.: 251113776
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)